Video Experimental Relacionado
Updated: Aug 12, 2026
11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
El espectro de hepatotoxicidad debido a las drogas
Lancet (London, England)
|August 23, 1986
Resumen
Los medicamentos comunes pueden dañar el hígado, causando diversos efectos tóxicos que imitan diversas enfermedades del hígado. Comprender la lesión hepática inducida por medicamentos es crucial para el diagnóstico preciso y la atención al paciente.
Área de la Ciencia:
- Hepatología Hepatología.
- Toxicología Toxicología.
- Farmacología Farmacología.
Sus antecedentes:
- Los medicamentos están frecuentemente asociados con lesiones hepáticas.
- La lesión hepática inducida por drogas (DILI) puede presentarse con un amplio espectro de características clínicas e histológicas.
- Reconocer el DILI es esencial para un manejo adecuado del paciente.
Objetivo del estudio:
- Revisar las diversas manifestaciones de la lesión hepática inducida por drogas.
- Para resaltar la importancia de considerar los medicamentos en el diagnóstico diferencial de las enfermedades del hígado.
Principales métodos:
- Revisión de la literatura sobre la lesión hepática inducida por drogas.
- Análisis de las presentaciones clínicas y patológicas de la hepatotoxicidad.
Principales resultados:
- La toxicidad de los medicamentos puede dañar directamente las células hepáticas (hepatocitos) a través de sus metabolitos.
- La hepatotoxicidad puede manifestarse como deposición de grasa microvesicular, fosfolipidosis o reacciones similares a las de la hepatitis viral o alcohólica.
- Otras presentaciones incluyen reacciones de hipersensibilidad, fibrosis, colestasis, enfermedades hepáticas vasculares y tumores hepáticos.
Conclusiones:
- La lesión hepática inducida por medicamentos es una causa significativa de enfermedad hepática.
- La presentación clínica de DILI es muy variable y puede imitar prácticamente cualquier enfermedad hepática nativa.
- Los médicos deben mantener un alto índice de sospecha de DILI en pacientes con anomalías hepáticas.
Videos de Conceptos Relacionados
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...